Area of research
Pulmonary and Respiratory Medicine · Cancer Research
Research interest
Research interests include Ferroptosis and cancer prognosis, MicroRNA in disease regulation, Cancer-related molecular mechanisms research, and Circular RNAs in diseases.
Inhibition of mitoNEET ameliorates traumatic brain injury-induced ferroptosis and cognitive dysfunction by stabilizing dihydroorotate dehydrogenase
The Interplay between Ferroptosis and Neuroinflammation in Central Neurological Disorders
Chinese expert consensus on allergen component resolved diagnosis
ncRNA-mediated SOX4 overexpression correlates with unfavorable outcomes and immune infiltration in hepatocellular carcinoma
Integrative analysis of single-cell and bulk RNA-sequencing data revealed disulfidptosis genes based molecular subtypes and a prognostic signature in lung adenocarcinoma
Tubastatin A potently inhibits GPX4 activity to potentiate cancer radiotherapy through boosting ferroptosis
High‑throughput screening identification of a small‑molecule compound that induces ferroptosis and attenuates the invasion and migration of hepatocellular carcinoma cells by targeting the STAT3/GPX4 axis
Identification of immune-related target and prognostic biomarkers in PBMC of hepatocellular carcinoma
A novel 25-ferroptosis-related gene signature for the prognosis of gliomas
Comprehensive analysis of the relationship between the ferroptosis and tumor-infiltrating immune cells, mutation, and immunotherapy in breast cancer
FAT4 Overexpression in Peripheral Blood Mononuclear Cells and Tumor Tissues is Associated With a Favorable Prognosis and Promotes Immune Cell Infiltration in Hepatocellular Carcinoma
A Coagulation-Related Gene-Based Prognostic Model for Invasive Ductal Carcinoma
Correction to: Aiduqing formula inhibits breast cancer metastasis by suppressing TAM/CXCL1-induced Treg differentiation and infiltration
Enhanced expression of miR-889 forecasts an unfavorable prognosis and facilitates cell progression in hepatocellular carcinoma
CD8+ T cells regulate tumour ferroptosis during cancer immunotherapy
Exosome-derived microRNAs contribute to prostate cancer chemoresistance
An individualized prognostic signature and multi-omics distinction for early stage hepatocellular carcinoma patients with surgical resection